<DOC>
	<DOCNO>NCT00552344</DOCNO>
	<brief_summary>The primary objective study assess safety long term therapy Certolizumab Pegol subject participate study C87085 [ NCT00552058 ] .</brief_summary>
	<brief_title>A Study Evaluate Safety Long Term Therapy Certolizumab Pegol Patients With Crohn 's Disease</brief_title>
	<detailed_description>This study consist : - Induction Period ( dose Weeks 0 , 2 , 4 ) - Maintenance Dosing ( dose every 4 week Week 260 ) - End Treatment Visit occur Week 262/Withdrawal Visit Safety Follow-up Visit ( SFU ; 12 week final dose )</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Certolizumab Pegol</mesh_term>
	<criteria>Subject participate study C87085 [ NCT00552058 ] subject complete study Week 6 Subject capable providing informed consent , must obtain prior study related procedure Have chest Xray take Visit 1 read qualify radiologist pulmonary physician , evidence current active Tuberculosis ( TB ) old inactive TB Subject take TB survey commit comply TB prophylaxis applicable Subject experience ongoing serious adverse event assess related study medication experience serious adverse event still assessable Subject intercurrent illness require termination treatment , serious infection ( e.g . TB , pneumonia , sepsis , pyelonephritis , fistula abscess ) Subject noncompliant TB prophylactic treatment ( applicable ) Subject chest Xray Visit 1 show abnormality suggestive malignancy active infection , include TB Female pregnant breast feed Female child bear age post puberty male practice effective birth control Subject expect receive live virus bacterial vaccination within 3 month first Study Medication administration , trial 3 month last dose study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>CDP 870</keyword>
	<keyword>Certolizumab Pegol</keyword>
	<keyword>CIMZIA</keyword>
	<keyword>Crohn 's Disease</keyword>
	<keyword>Crohn Disease</keyword>
	<keyword>CD Induction</keyword>
	<keyword>Induction</keyword>
	<keyword>Clinical response</keyword>
	<keyword>Clinical remission</keyword>
</DOC>